BW A868C is a hydantoin compound that is structurally related to the DP receptor agonist BW 245C. BW A868C antagonizes the prostaglandin D2 and BW 245C-induced activation of human platelet adenylate cyclase. It reverses the anti-aggregatory effects of DP receptor agonists in a dose-dependent manner. Likewise, BW...

25H-NBOMe imine analog differs from 25H-NBOMe by having a double bond linking the N-(2-methoxybenzyl) group to 25H. The properties of this compound have not been evaluated. This product is intended for research and forensic applications.Formal Name: (E)-2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzylidene)ethanamine. CAS...

NMT (Cay-12067) is an analytical reference standard categorized as a tryptamine. It is a minor component of ayahuasca, a botanical mixture that has hallucinogenic properties. NMT is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.Formal Name:...

Astragaloside IV is a bioactive saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine. It dose-dependently inhibits human adenovirus type 3 (HAdV-3) in A549 cells (IC50 = 23 µM, LC50 = 865 µM). It inhibits replication of HAdV-3 and decreases...

Cysteinyl leukotriene receptor 2 (CysLT2) is a G protein-coupled receptor that mediates the actions of leukotriene C4 (LTC4), LTD4, and, to a lesser extent, LTE4. It is expressed primarily in the heart, placenta, spleen, lymph nodes, and peripheral blood leukocytes. Signaling induced by LTC4 through the CysLT2...